ModelEdge

Arena Pharmaceuticals Inc
0001080709
Filing Type8-K
Filing Date3/10/2022
Updated3/11/22, 1:54 AM

Filing

8-K
Earnings Release

Exhibits

8-KCompleting Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
EX-3.1EXHIBIT 3.1
EX-3.2EXHIBIT 3.2